Batu Biologics Launches #starvethetumor Campaign

Batu Biologics Launches #starvethetumor Crowdfunding Campaign for ValloVax Cancer Immunotherapy

Company is hosting a press conference on May 11th, 2017 to discuss our strategy for ValloVax development

Batu Biologics, an immuno-oncology company dedicated to studying blood vessel formation within tumors, announced today the launch of an equity crowdfunding campaign on EquityNet.

Read the full article at businesswire.com

0